These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20651933)

  • 1. Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil.
    Gazzinelli MF; Lobato L; Matoso L; Avila R; de Cassia Marques R; Shah Brown A; Correa-Oliveira R; Bethony JM; Diemert DJ
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e749. PubMed ID: 20651933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted in Developed and Developing Countries.
    Diemert DJ; Lobato L; Styczynski A; Zumer M; Soares A; Gazzinelli MF
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005327. PubMed ID: 28114401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public engagement for the conduct of a controlled human infection study testing vaccines against Necator americanus (hookworm) in areas of active hookworm transmission in Brazil.
    Ribeiro LB; Gazzinelli A; Santiago HDC; Fiuza JA; Lobato L; Correa de Oliveira R; Gazzinelli Bethony MF
    PLoS One; 2024; 19(6):e0299022. PubMed ID: 38829836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial.
    Adegnika AA; de Vries SG; Zinsou FJ; Honkepehedji YJ; Dejon Agobé JC; Vodonou KG; Bikangui R; Bouyoukou Hounkpatin A; Bache EB; Massinga Loembe M; van Leeuwen R; Molemans M; Kremsner PG; Yazdanbakhsh M; Hotez PJ; Bottazzi ME; Li G; Bethony JM; Diemert DJ; Grobusch MP;
    Lancet Infect Dis; 2021 Feb; 21(2):275-285. PubMed ID: 32926834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
    Diemert DJ; Freire J; Valente V; Fraga CG; Talles F; Grahek S; Campbell D; Jariwala A; Periago MV; Enk M; Gazzinelli MF; Bottazzi ME; Hamilton R; Brelsford J; Yakovleva A; Li G; Peng J; Correa-Oliveira R; Hotez P; Bethony J
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005574. PubMed ID: 28464026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential economic value of a hookworm vaccine.
    Lee BY; Bacon KM; Bailey R; Wiringa AE; Smith KJ
    Vaccine; 2011 Feb; 29(6):1201-10. PubMed ID: 21167860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Theater in the education of children and teenagers participating in a clinical trial].
    Gazzinelli MF; Souza Vd; Araújo LH; Costa Rde M; Soares AN; Maia CP
    Rev Saude Publica; 2012 Dec; 46(6):999-1006. PubMed ID: 23503538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative.
    Hotez PJ; Zhan B; Bethony JM; Loukas A; Williamson A; Goud GN; Hawdon JM; Dobardzic A; Dobardzic R; Ghosh K; Bottazzi ME; Mendez S; Zook B; Wang Y; Liu S; Essiet-Gibson I; Chung-Debose S; Xiao S; Knox D; Meagher M; Inan M; Correa-Oliveira R; Vilk P; Shepherd HR; Brandt W; Russell PK
    Int J Parasitol; 2003 Sep; 33(11):1245-58. PubMed ID: 13678639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naïve adults.
    Diemert DJ; Zumer M; Campbell D; Grahek S; Li G; Peng J; Elena Bottazzi M; Hotez P; Bethony J
    Vaccine; 2022 Oct; 40(42):6084-6092. PubMed ID: 36114129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of human participants with attenuated Necator americanus hookworm larvae and human challenge in Australia: a dose-finding study and randomised, placebo-controlled, phase 1 trial.
    Chapman PR; Webster R; Giacomin P; Llewellyn S; Becker L; Pearson MS; De Labastida Rivera F; O'Rourke P; Engwerda CR; Loukas A; McCarthy JS
    Lancet Infect Dis; 2021 Dec; 21(12):1725-1736. PubMed ID: 34419209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hookworm vaccines: past, present, and future.
    Loukas A; Bethony J; Brooker S; Hotez P
    Lancet Infect Dis; 2006 Nov; 6(11):733-41. PubMed ID: 17067922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm.
    Bottazzi ME; Brown AS
    Expert Rev Vaccines; 2008 Dec; 7(10):1481-92. PubMed ID: 19053205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Knowledge and willingness to participate in research: a descriptive study of volunteers in a clinical trial].
    Lobato L; Gazzinelli MF; Gazzinelli A; Soares AN
    Cad Saude Publica; 2014 Jun; 30(6):1305-14. PubMed ID: 25099053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial.
    Vandormael A; Adam M; Greuel M; Bärnighausen T
    Trials; 2020 Jun; 21(1):469. PubMed ID: 32493460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising informed consent for participants in a randomised controlled trial in rural Uganda: a comparative prospective cohort mixed-methods study.
    Ditai J; Kanyago J; Nambozo MR; Odeke NM; Abeso J; Dusabe-Richards J; Olupot-Olupot P; Carrol ED; Medina-Lara A; Gladstone M; Storr J; Faragher B; Weeks AD
    Trials; 2018 Dec; 19(1):699. PubMed ID: 30577809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting.
    Bartsch SM; Hotez PJ; Hertenstein DL; Diemert DJ; Zapf KM; Bottazzi ME; Bethony JM; Brown ST; Lee BY
    Vaccine; 2016 Apr; 34(19):2197-206. PubMed ID: 27002501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.